Trial · NCT03366298
Outcomes14
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 14 of 14
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Plasma Catecholamine Levels (Maximum Concentration, Cmax) | 3 hours | pg/ml | MEAN | |
| PRIMARY | Plasma Catecholamine Levels (Time to Maximum Concentration, Tmax) | 3 hours | minutes | MEAN | |
| PRIMARY | Plasma Catecholamine Levels (Maximum Concentration, Area-under-curve (AUC)) | At at the following timepoints following injection: 5, 10, 15, 20, 30, 45, 60, 80, 100, 120 and 180 minutes | hr*pg/ml | MEAN | |
| SECONDARY | Change in Heart Rate Following Self-injection of Adrenaline (300mcg, 500mcg) on Separate Occasions. | 3 hours | |||
| SECONDARY | Change in Blood Pressure Following Self-injection of Adrenaline (300mcg, 500mcg) on Separate Occasions. | 3 hours | |||
| SECONDARY | Change in Stroke Volume Following Self-injection of Adrenaline (300mcg, 500mcg) on Separate Occasions. | 3 hours | |||
| SECONDARY | Impact of Needle Length on Pharmacokinetics (Plasma Catecholamine Levels: Cmax) | 3 hours | |||
| SECONDARY | Impact of Needle Length on Pharmacokinetics (Plasma Catecholamine Levels: Tmax) | 3 hours | |||
| SECONDARY | Impact of Needle Length on Pharmacokinetics (Plasma Catecholamine Levels: AUC) | 3 hours | |||
| SECONDARY | Impact of Needle Length on Pharmacodynamics (Cardiovascular Parameters: Heart Rate) | 3 hours | |||
| SECONDARY | Impact of Needle Length on Pharmacodynamics (Cardiovascular Parameters: Blood Pressure) | 3 hours | |||
| SECONDARY | Impact of Needle Length on Pharmacodynamics (Cardiovascular Parameters: Stroke Volume) | 3 hours | |||
| SECONDARY | Adverse Events Following Self-administration of Adrenaline Via Autoinjector Device | 1 day | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Change in Health-related Quality of Life (HRQL) as Measured Using FAQLQ | 1 month |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03366298/outcomes